According to GlobalData’s medical device pipeline database, 65 Hyaluronic Acid Fillers devices are in various stages of development globally. GlobalData’s report Hyaluronic Acid Fillers provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 52 are in active development, while the remaining 18 are in an inactive stage of development. There are ten products in the early stages of development, and the remaining 42 are in the late stages of development.
Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of total HA is found in the skin, and it is produced by dermal fibroblasts, endothelial cells, synovial cells, adventitial cells, smooth muscle cells, and oocytes. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. One unit refers to one mL of Hyaluronic Acid Filler.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Hyaluronic Acid Fillers pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Hyaluronic Acid Fillers devices. Overall, most of these Hyaluronic Acid Fillers pipeline devices are being developed by private entities.
Key players involved in the active development of Hyaluronic Acid Fillers include LG Chem, Allergan Aesthetics, Evolus, Hugel, BioPlus, Sinclair Pharma, Jinwoo Bio, Fillmed Laboratoires, Hallura and Medytox.
For a complete picture of the developmental pipeline for Hyaluronic Acid Fillers devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.